Press Releases Resonance Health Limited

Equities

Market Closed - Australian S.E. Other stock markets 06:59:09 28/06/2024 BST			5-day change	1st Jan Change
0.059 ^AUD	-4.84%		-1.67%	-1.67%

06-07	Resonance Health Receives R&D Tax Rebate of AU$818,706	MT
05-31	Resonance Health Acquires TrialsWest	MT

Resonance Health : Quarterly Activities/Appendix 4C Cash Flow Report	01/05/22	PU
VGI Health Technology Limited (NSX:VTL) Contract with Resonance Health (ASX:RHT)	24/01/22	AQ
Resonance Health : US FDA Clearance for LiverSmart	29/12/21	PU
Resonance Health : Investor Presentation - Positioning for Growth	25/11/21	PU
Resonance Health : THALASSEMIA INTERNATIONAL FEDERATION TO DEPLOY FERRISMART	15/11/21	PU
EASL Digital #NAFLDSummit 2021: Resonance Health presents, HepaFat-AI results equivalent to a conventional MRS technique	24/09/21	PU
Resonance Health : Appointment of GM - Global Sales & Marketing	28/07/21	PU
Resonance Health : News - June 2021	18/06/21	PU
Resonance Health : HepaFat-AI Receives CE Marking	24/02/21	PU
Resonance Health : HepaFat-AI gains US FDA clearance	08/12/20	PU
R&D Update: New Pulmonary Embolism AI Solution Developed	06/10/20	PU
Resonance Health : Files New Provisional Patent	25/05/20	PU
Resonance Health : Partners with Siemens Healthineers	29/11/19	PU
Resonance Health : Investor Presentation November 2019	25/11/19	PU
Resonance Health : New Artificial Intelligence Tool for Automated Assessment of Liver Fat	21/11/19	PU
Resonance Health : News - April 2019	29/04/19	PU
Resonance Health : Response to ASX Price and Volume Query	11/12/18	PU
Resonance Health : FDA Clearance Granted for FerriSmart	02/12/18	PU
Resonance Health : R&D Tax Incentive	20/11/18	PU
Resonance Health : Change of Director's Interest Notice	16/11/18	PU

No results for this search